Australia markets closed

VTGN Jan 2025 5.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.95000.0000 (0.00%)
At close: 12:03PM EDT
Full screen
Previous close1.9500
Open1.9500
Bid1.6000
Ask2.7000
Strike5.00
Expiry date2025-01-17
Day's range1.9500 - 1.9500
Contract rangeN/A
Volume3
Open interest72
  • Insider Monkey

    VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript

    VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript June 11, 2024 Operator: Greetings, and welcome to the Vistagen Therapeutics Fiscal Year-End 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. […]

  • Business Wire

    Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

    SOUTH SAN FRANCISCO, Calif., June 11, 2024--Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today reported financial results for its fiscal year ended March 31, 2024, and provided a corporate update.

  • Business Wire

    Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024

    SOUTH SAN FRANCISCO, Calif., June 07, 2024--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced it will host a conference call and webcast on Tuesday, June 11, 2024, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2024 ended March 31, 2024 and provide a corporate update.